195892 | 195892 | PNU 166148 in Treating Patients With Metastatic Solid Tumors | Active, not recruiting | No Results Available | Unspecified Adult Solid Tumor, Protocol Specific | Drug: mureletecan | https://ClinicalTrials.gov/show/NCT00004076 |
195893 | 195893 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | Completed | No Results Available | Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific | Drug: tanespimycin | https://ClinicalTrials.gov/show/NCT00004075 |
195894 | 195894 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | Completed | No Results Available | Advanced Adult Primary Liver Cancer|Anaplastic Thyroid Cancer|Bone Metastases|Carcinoma of the Appendix|Distal Urethral Cancer|Fallopian Tube Cancer|Gastrinoma|Glucagonoma|Inflammatory Breast Cancer|Insulinoma|Liver Metastases|Localized Unresectable Adult | Biological: recombinant interleukin-12|Biological: ABI-007/carboplatin/trastuzumab | https://ClinicalTrials.gov/show/NCT00004074 |
195895 | 195895 | Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Completed | No Results Available | Brain and Central Nervous System Tumors | Drug: suramin|Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00004073 |
195896 | 195896 | O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma | Completed | No Results Available | Multiple Myeloma and Plasma Cell Neoplasm | Drug: O6-benzylguanine|Drug: carmustine | https://ClinicalTrials.gov/show/NCT00004072 |
195897 | 195897 | Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | Completed | No Results Available | Prostate Cancer | Drug: leflunomide|Drug: mitoxantrone hydrochloride|Drug: prednisone | https://ClinicalTrials.gov/show/NCT00004071 |
195898 | 195898 | Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer | Active, not recruiting | No Results Available | Head and Neck Cancer | Biological: interleukin-12 gene | https://ClinicalTrials.gov/show/NCT00004070 |
195899 | 195899 | Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor | Completed | No Results Available | Brain and Central Nervous System Tumors | Drug: irinotecan hydrochloride|Drug: temozolomide|Procedure: conventional surgery|Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00004068 |
195871 | 195871 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | Active, not recruiting | No Results Available | Head and Neck Cancer | Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: paclitaxel|Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00004097 |
195872 | 195872 | Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | Completed | No Results Available | Lung Cancer | Drug: carboplatin|Drug: vinorelbine ditartrate | https://ClinicalTrials.gov/show/NCT00004096 |
195873 | 195873 | Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | Completed | No Results Available | Bladder Cancer|Breast Cancer|Colorectal Cancer|Kidney Cancer|Lung Cancer|Pancreatic Cancer | Drug: gemcitabine hydrochloride|Drug: irinotecan hydrochloride | https://ClinicalTrials.gov/show/NCT00004095 |
195874 | 195874 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | Active, not recruiting | No Results Available | Head and Neck Cancer | Drug: carboplatin|Drug: fluorouracil|Drug: hydroxyurea|Drug: paclitaxel|Procedure: conventional surgery|Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00004094 |
195875 | 195875 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | Terminated | No Results Available | Lung Cancer | Drug: carboplatin|Drug: Gemcitabine|Drug: paclitaxel|Drug: vinorelbine|Radiation: radiation therapy|Drug: Navelbine|Drug: Taxol | https://ClinicalTrials.gov/show/NCT00004093 |
195876 | 195876 | Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer | Completed | Has Results | Breast Cancer | Biological: filgrastim|Drug: carboplatin|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel|Drug: thiotepa|Procedure: peripheral blood stem cell transplantation | https://ClinicalTrials.gov/show/NCT00004092 |
195877 | 195877 | Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results | Completed | No Results Available | Cervical Cancer | Other: Papanicolaou test|Other: cytology specimen collection procedure|Other: fluorescent antibody technique|Procedure: colposcopic biopsy|Procedure: study of high risk factors | https://ClinicalTrials.gov/show/NCT00004091 |
195878 | 195878 | Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors | Completed | No Results Available | Unspecified Adult Solid Tumor, Protocol Specific | Drug: cisplatin|Drug: gemcitabine hydrochloride | https://ClinicalTrials.gov/show/NCT00004090 |
195879 | 195879 | Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer | Completed | No Results Available | Head and Neck Cancer | Biological: filgrastim|Drug: fluorouracil|Drug: hydroxyurea|Drug: paclitaxel|Procedure: conventional surgery|Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00004089 |
195880 | 195880 | Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma | Active, not recruiting | No Results Available | Multiple Myeloma and Plasma Cell Neoplasm | Biological: filgrastim|Biological: recombinant interferon alfa|Drug: busulfan|Drug: cyclophosphamide|Drug: melphalan|Drug: pamidronate disodium|Drug: thalidomide|Procedure: peripheral blood stem cell transplantation | https://ClinicalTrials.gov/show/NCT00004088 |
195881 | 195881 | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer | Completed | No Results Available | Colorectal Cancer|Pancreatic Cancer | Biological: filgrastim|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: indium In 111 monoclonal antibody MN-14|Radiation: yttrium Y 90 monoclonal antibody MN-14 | https://ClinicalTrials.gov/show/NCT00004087 |
195882 | 195882 | Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer | Active, not recruiting | No Results Available | Leukemia|Lymphoma | Biological: filgrastim|Drug: cisplatin|Drug: cytarabine|Drug: etoposide|Drug: ifosfamide|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: indium In 111 LL2 IgG|Radiation: yttrium Y 90 epratuzumab | https://ClinicalTrials.gov/show/NCT00004086 |
195883 | 195883 | Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | Completed | No Results Available | Breast Cancer | Biological: filgrastim|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: yttrium Y 90 monoclonal antibody MN-14 | https://ClinicalTrials.gov/show/NCT00004085 |
195884 | 195884 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia | Completed | No Results Available | Leukemia|Lymphoma | Radiation: indium In 111 LL2 IgG|Radiation: yttrium Y 90 epratuzumab | https://ClinicalTrials.gov/show/NCT00004084 |
195885 | 195885 | Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer | Completed | No Results Available | Ovarian Cancer | Drug: cisplatin liposomal | https://ClinicalTrials.gov/show/NCT00004083 |
195886 | 195886 | Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors | Completed | No Results Available | Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer | Drug: carboplatin|Drug: docetaxel|Drug: gemcitabine hydrochloride | https://ClinicalTrials.gov/show/NCT00004082 |
195887 | 195887 | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer | Completed | No Results Available | Ovarian Cancer|Peritoneal Cavity Cancer | Drug: docetaxel | https://ClinicalTrials.gov/show/NCT00004081 |
195888 | 195888 | Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors | Completed | No Results Available | Brain and Central Nervous System Tumors | Biological: recombinant adenovirus-p53 SCH-58500|Procedure: conventional surgery | https://ClinicalTrials.gov/show/NCT00004080 |
195889 | 195889 | Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors | Completed | No Results Available | Unspecified Adult Solid Tumor, Protocol Specific | Drug: SarCNU|Other: pharmacological study|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT00004079 |
195890 | 195890 | Irinotecan in Treating Children With Refractory Solid Tumors | Completed | No Results Available | Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood Infratentorial Ependymoma|Childhood Oligodendro | Drug: irinotecan hydrochloride | https://ClinicalTrials.gov/show/NCT00004078 |
195891 | 195891 | Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer | Completed | No Results Available | Testicular Germ Cell Tumor | Drug: cisplatin|Drug: ifosfamide|Drug: paclitaxel | https://ClinicalTrials.gov/show/NCT00004077 |
195900 | 195900 | Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 | Active, not recruiting | No Results Available | Breast Cancer | Biological: herceptin|Drug: adriamycin|Drug: cyclophosphamide|Drug: taxol | https://ClinicalTrials.gov/show/NCT00004067 |